8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer)
Published . Updated .
Key takeaways
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Lexeo Therapeutics filed an 8-K with the SEC on Nov 16 (a notice of a material company event).
Directly affected
- LXEO Lexeo Therapeutics
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Lexeo Therapeutics belongs to, so it often moves with news about it.
- AMGN Amgen+15.9% 30d
Amgen is a peer of Lexeo Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- GILD Gilead Sciences+16.4% 30d
Gilead Sciences is a peer of Lexeo Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- MRNA Moderna+22.4% 30d
Moderna is a peer of Lexeo Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- ARGX argenx SE-11.9% 9d
argenx SE is a peer of Lexeo Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- RVMD Revolution Medicines
Revolution Medicines is a peer of Lexeo Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| LXEO | +9.76% | +7.14% | base | after close | after close | after close | after close |
| XLV | -0.28% | +0.04% | base | after close | after close | after close | after close |
| AMGN | -0.08% | +0.56% | base | after close | after close | after close | after close |
| GILD | +0.80% | +0.98% | base | after close | after close | after close | after close |
| MRNA | +20.51% | +11.41% | base | after close | after close | after close | after close |
| ARGX | +0.34% | +1.85% | base | after close | after close | after close | after close |
| RVMD | +16.24% | +4.86% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-16 AccNo: 0001193125-26-462015 Size: 28 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Lexeo Therapeutics (LXEO) since “8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer),” compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| Amgen (AMGN) | three days earlier | +0.56% | final price |
| Amgen (AMGN) | five days earlier | -0.08% | final price |
| Argenx Se (ARGX) | three days earlier | +1.85% | final price |
| Argenx Se (ARGX) | five days earlier | +0.34% | final price |
| Gilead Sciences (GILD) | three days earlier | +0.98% | final price |
| Gilead Sciences (GILD) | five days earlier | +0.80% | final price |
| Lexeo Therapeutics (LXEO) | three days earlier | +7.14% | final price |
| Lexeo Therapeutics (LXEO) | five days earlier | +9.76% | final price |
| Moderna (MRNA) | three days earlier | +11.41% | final price |
| Moderna (MRNA) | five days earlier | +20.51% | final price |
| Revolution Medicines (RVMD) | three days earlier | +4.86% | final price |
| Revolution Medicines (RVMD) | five days earlier | +16.24% | final price |
| Select Sector Spdr Tr (XLV) | three days earlier | +0.04% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | -0.28% | final price |
Congressional trades in the stocks in this story
- Rep. David J. Taylor sold Amgen (AMGN), worth $1,001 - $15,000 on 3 Nov 2026. That is 13 days before publication. Filed 12 Nov 2026. View the filing.
- Sen. Sheldon Whitehouse sold Amgen (AMGN) (held by a spouse), worth $15,001 - $50,000 on 15 Oct 2026. That is 32 days before publication. Filed 2 Nov 2026. View the filing.
- Rep. David J. Taylor bought Amgen (AMGN), worth $1,001 - $15,000 on 22 Sep 2026. That is 55 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. Gilbert Cisneros bought Moderna (MRNA), worth $1,001 - $15,000 on 20 Oct 2026. That is 27 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Maria Elvira Salazar sold Moderna (MRNA), worth $1,001 - $15,000 on 24 Sep 2026. That is 53 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Moderna (MRNA) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 73 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Gilbert Cisneros bought Argenx Se (ARGX), worth $1,001 - $15,000 on 27 Oct 2026. That is 20 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Argenx Se (ARGX), worth $1,001 - $15,000 on 15 Oct 2026. That is 32 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Argenx Se (ARGX), worth $15,001 - $50,000 on 14 Oct 2026. That is 33 days before publication. Filed 10 Nov 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Lexeo Therapeutics (LXEO)
Companies carried with this story
- LXEO Lexeo Therapeutics
For “8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer),” Lexeo Therapeutics (LXEO) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> LXEO
- XLV Select Sector Spdr Tr
For “8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer),” Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence. Reason on file: Health Care Select Sector SPDR holds the health sector that Lexeo Therapeutics belongs to, so it often moves with news about it
- AMGN Amgen
For “8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer),” Amgen (AMGN) is linked, with no stored direction, medium confidence. Reason on file: Amgen is a peer of Lexeo Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news
- GILD Gilead Sciences
Gilead Sciences (GILD) is linked, with no stored direction, medium confidence in the 16 Nov 2026 story “8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer).” Reason on file: Gilead Sciences is a peer of Lexeo Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news
- MRNA Moderna
In “8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer),” Moderna (MRNA) is linked, with no stored direction, medium confidence. Reason on file: Moderna is a peer of Lexeo Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news
- ARGX Argenx Se
Argenx Se (ARGX) is linked, with no stored direction, medium confidence in the 16 Nov 2026 story “8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer).” Reason on file: argenx SE is a peer of Lexeo Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news
- RVMD Revolution Medicines
In “8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer),” Revolution Medicines (RVMD) is linked, with no stored direction, medium confidence. Reason on file: Revolution Medicines is a peer of Lexeo Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news
How “8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer)” reaches Lexeo Therapeutics (LXEO)
The 16 Nov 2026 story “8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer)” names Lexeo Therapeutics (LXEO) because of this story.
For Lexeo Therapeutics (LXEO), the reason on file says SEC 8-K filing -> direct issuer disclosure -> LXEO
Also listed, Select Sector Spdr Tr (XLV): Health Care Select Sector SPDR holds the health sector that Lexeo Therapeutics belongs to, so it often moves with news about it
The price range for Lexeo Therapeutics (LXEO), and the dates in the story
AMGN traded between 424.75 and 482.71 across 20 sessions. The latest close on file is 466.99.
How strong the case is around Lexeo Therapeutics (LXEO)
46 out of 100
“8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.